EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.1.1.37 | malate dehydrogenase |
breast cancer cell line |
- |
760678 |
1.1.1.40 | malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) |
breast cancer cell line |
breast cancer cell line |
286740, 286741 |
1.1.1.51 | 3(or 17)beta-hydroxysteroid dehydrogenase |
breast cancer cell line |
- |
762076 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
breast cancer cell line |
- |
687146, 762076 |
1.11.1.12 | phospholipid-hydroperoxide glutathione peroxidase |
breast cancer cell line |
COH-BR1 cells |
675048 |
1.13.11.33 | arachidonate 15-lipoxygenase |
breast cancer cell line |
- |
673030 |
1.5.3.16 | spermine oxidase |
breast cancer cell line |
the antiproliferative effects of analogue N1,N1-bis(ethyl)norspermine in MDA-MB-231 cells are mediated in part through the production of H2O2 by SMO(PAOh1) and by the export of acetylated polyamines formed by the activity of spermidine/spermine N1-acetyltransferase |
692977 |
2.4.1.223 | glucuronosyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase |
breast cancer cell line |
epithelial breast carcinoma cell line |
758941 |
2.4.1.225 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase |
breast cancer cell line |
- |
758941 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
breast cancer cell line |
- |
489202 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
breast cancer cell line |
benign cell line HMT 3522, non-metastatic cell line BT 474, metastatic cell lines ZR75-1, T-47D, MCF-7 |
684219 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
breast cancer cell line |
ppGalNAc-T1 detection in all studied breast cancer cell lines |
684219 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
breast cancer cell line |
ppGalNAc-T2 detection in all studied breast cancer cell lines |
684219 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
breast cancer cell line |
ppGalNAc-T3 nearly undetectable in breast cancer cell line HMT-3522 |
684219 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
breast cancer cell line |
ppGalNAc-T4 undetectable in breast cancer cell line ZR75-1 cell |
684219 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
breast cancer cell line |
ppGalNAc-T6 nearly undetectable in breast cancer cell line HMT-3522 |
684219 |
2.7.1.137 | phosphatidylinositol 3-kinase |
breast cancer cell line |
- |
688967 |
2.7.10.1 | receptor protein-tyrosine kinase |
breast cancer cell line |
- |
490356, 490365, 490371, 490389 |
2.7.10.1 | receptor protein-tyrosine kinase |
breast cancer cell line |
markedly elevated ERBB3 mRNA levels are demonstrated in certain human mammary tumor cell lines |
490316 |
2.7.10.2 | non-specific protein-tyrosine kinase |
breast cancer cell line |
- |
490442, 490443, 490469 |
2.7.10.2 | non-specific protein-tyrosine kinase |
breast cancer cell line |
upregulated expression of syk is observed in aggressive, metastasizing mammary gland tumours but not in well differentiated, non-metastasizing tumors |
490457 |
2.7.12.2 | mitogen-activated protein kinase kinase |
breast cancer cell line |
- |
491878 |
2.8.2.4 | estrone sulfotransferase |
breast cancer cell line |
- |
645898 |
2.8.2.4 | estrone sulfotransferase |
breast cancer cell line |
hormone-dependent MCF-7 and T47D, hormone-independent MDA-MB-231 |
645897 |
3.1.3.67 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase |
breast cancer cell line |
- |
651205, 677869 |
3.2.1.166 | heparanase |
breast cancer cell line |
metastatic breast carcinoma cell lines show a substantial increase in hpa gene expression |
694315 |
3.4.21.46 | complement factor D |
breast cancer cell line |
PDGF-D high-expressing breast cancer cell line SUM-149 is more invasive compared to low-expressing cell lines |
707940 |
3.4.21.68 | t-Plasminogen activator |
breast cancer cell line |
transformed, carcinoma |
29575 |
3.4.21.B28 | fibroblast activation protein alpha subunit |
breast cancer cell line |
- |
678473 |
3.4.21.B39 | stratum corneum tryptic enzyme |
breast cancer cell line |
high expression |
670977 |
3.4.21.B39 | stratum corneum tryptic enzyme |
breast cancer cell line |
no expression |
670978 |
3.4.21.B42 | hippostasin |
breast cancer cell line |
KLK11 is upregulated by estrogens, dexamethasone, androgens and progestins in breast cancer cell lines |
691150 |
3.4.24.80 | membrane-type matrix metalloproteinase-1 |
breast cancer cell line |
- |
669212 |
3.4.24.86 | ADAM 17 endopeptidase |
breast cancer cell line |
TACE expression measured by immunohistochemical analysis is observed in 183 of 383 breast carcinomas. TACE expression is predominantly seen in tumors with high levels of released human epidermal growth factor-4 receptor intracellular domain (4ICD) and membranous human epidermal growth factor-4 receptor |
695437 |
3.5.1.98 | histone deacetylase |
breast cancer cell line |
- |
697650 |
3.6.1.56 | 2-hydroxy-dATP diphosphatase |
breast cancer cell line |
MTH1 expression is not associated with proliferation rate |
715082 |
4.1.2.27 | sphinganine-1-phosphate aldolase |
breast cancer cell line |
- |
682517 |
6.3.5.4 | asparagine synthase (glutamine-hydrolysing) |
breast cancer cell line |
carcinoma |
1710 |